Literature DB >> 20223821

Protease-activated receptor-1 (PAR1) acts via a novel Galpha13-dishevelled axis to stabilize beta-catenin levels.

Hagit Turm1, Myriam Maoz1, Vered Katz1, Yong-Jun Yin1, Steffan Offermanns2, Rachel Bar-Shavit3.   

Abstract

We have previously shown a novel link between hPar-1 (human protease-activated receptor-1) and beta-catenin stabilization. Although it is well recognized that Wnt signaling leads to beta-catenin accumulation, the role of PAR1 in the process is unknown. We provide here evidence that PAR1 induces beta-catenin stabilization independent of Wnt, Fz (Frizzled), and the co-receptor LRP5/6 (low density lipoprotein-related protein 5/6) and identify selective mediators of the PAR1-beta-catenin axis. Immunohistological analyses of hPar1-transgenic (TG) mouse mammary tissues show the expression of both Galpha(12) and Galpha(13) compared with age-matched control counterparts. However, only Galpha(13) was found to be actively involved in PAR1-induced beta-catenin stabilization. Indeed, a dominant negative form of Galpha(13) inhibited both PAR1-induced Matrigel invasion and Lef/Tcf (lymphoid enhancer factor/T cell factor) transcription activity. PAR1-Galpha(13) association is followed by the recruitment of DVL (Dishevelled), an upstream Wnt signaling protein via the DIX domain. Small interfering RNA-Dvl silencing leads to a reduction in PAR1-induced Matrigel invasion, inhibition of Lef/Tcf transcription activity, and decreased beta-catenin accumulation. It is of note that PAR1 also promotes the binding of beta-arrestin-2 to DVL, suggesting a role for beta-arrestin-2 in PAR1-induced DVL phosphorylation dynamics. Although infection of small interfering RNA-LRP5/6 or the use of the Wnt antagonists, SFRP2 (soluble Frizzled-related protein 2) or SFRP5 potently reduced Wnt3A-mediated beta-catenin accumulation, no effect was observed on PAR1-induced beta-catenin stabilization. Collectively, our data show that PAR1 mediates beta-catenin stabilization independent of Wnt. We propose here a novel cascade of PAR1-induced Galpha(13)-DVL axis in cancer and beta-catenin stabilization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20223821      PMCID: PMC2865281          DOI: 10.1074/jbc.M109.072843

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  71 in total

1.  CDX2 is mutated in a colorectal cancer with normal APC/beta-catenin signaling.

Authors:  L T da Costa; T C He; J Yu; A B Sparks; P J Morin; K Polyak; S Laken; B Vogelstein; K W Kinzler
Journal:  Oncogene       Date:  1999-09-02       Impact factor: 9.867

Review 2.  Dishevelled: at the crossroads of divergent intracellular signaling pathways.

Authors:  M Boutros; M Mlodzik
Journal:  Mech Dev       Date:  1999-05       Impact factor: 1.882

Review 3.  Wnt signaling and cancer.

Authors:  P Polakis
Journal:  Genes Dev       Date:  2000-08-01       Impact factor: 11.361

Review 4.  The developmental biology of Dishevelled: an enigmatic protein governing cell fate and cell polarity.

Authors:  John B Wallingford; Raymond Habas
Journal:  Development       Date:  2005-10       Impact factor: 6.868

Review 5.  Beta-catenin, cancer, and G proteins: not just for frizzleds anymore.

Authors:  Craig C Malbon
Journal:  Sci STKE       Date:  2005-07-12

6.  G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the {beta}-catenin pathway.

Authors:  Ming Yang; Wendy W Zhong; Neelam Srivastava; Anthony Slavin; Jianxin Yang; Timothy Hoey; Songzhu An
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-18       Impact factor: 11.205

7.  The mechanism of endogenous receptor activation functionally distinguishes prototype canonical and noncanonical Wnts.

Authors:  Guizhong Liu; Anna Bafico; Stuart A Aaronson
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

8.  DIX domains of Dvl and axin are necessary for protein interactions and their ability to regulate beta-catenin stability.

Authors:  S Kishida; H Yamamoto; S Hino; S Ikeda; M Kishida; A Kikuchi
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

9.  Essential role for Galpha13 in endothelial cells during embryonic development.

Authors:  Kathleen M Ruppel; David Willison; Hiroshi Kataoka; Alice Wang; Yao-Wu Zheng; Ivo Cornelissen; Liya Yin; Shan Mei Xu; Shaun R Coughlin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-26       Impact factor: 11.205

10.  Axin contains three separable domains that confer intramolecular, homodimeric, and heterodimeric interactions involved in distinct functions.

Authors:  Wen Luo; Haiying Zou; Lihua Jin; Shuyong Lin; Qinxi Li; Zhiyun Ye; Hongliang Rui; Sheng-Cai Lin
Journal:  J Biol Chem       Date:  2004-12-05       Impact factor: 5.157

View more
  15 in total

1.  Protease-activated-receptor-2 affects protease-activated-receptor-1-driven breast cancer.

Authors:  Mohammad Jaber; Miriam Maoz; Arun Kancharla; Daniel Agranovich; Tamar Peretz; Sorina Grisaru-Granovsky; Beatrice Uziely; Rachel Bar-Shavit
Journal:  Cell Mol Life Sci       Date:  2013-11-01       Impact factor: 9.261

2.  Activated protein C promotes protease-activated receptor-1 cytoprotective signaling through β-arrestin and dishevelled-2 scaffolds.

Authors:  Unice J K Soh; JoAnn Trejo
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-21       Impact factor: 11.205

3.  DVL as a scaffold protein capturing classical GPCRs.

Authors:  Hagit Turm; Sorina Grisaru-Granvosky; Myriam Maoz; Stefan Offermanns; Rachel Bar-Shavit
Journal:  Commun Integr Biol       Date:  2010-11-01

Review 4.  Regulation of protease-activated receptor signaling by post-translational modifications.

Authors:  Neil Grimsey; Antonio G Soto; JoAnn Trejo
Journal:  IUBMB Life       Date:  2011-03-24       Impact factor: 3.885

5.  A novel role for factor VIII and thrombin/PAR1 in regulating hematopoiesis and its interplay with the bone structure.

Authors:  Anna Aronovich; Yaniv Nur; Elias Shezen; Chava Rosen; Yael Zlotnikov Klionsky; Irit Milman; Liran Yarimi; David Hagin; Gidi Rechavi; Uriel Martinowitz; Takashi Nagasawa; Paul S Frenette; Dalit Tchorsh-Yutsis; Yair Reisner
Journal:  Blood       Date:  2013-08-27       Impact factor: 22.113

Review 6.  The role and mechanism of β‑arrestins in cancer invasion and metastasis (Review).

Authors:  Qing Song; Qing Ji; Qi Li
Journal:  Int J Mol Med       Date:  2017-11-27       Impact factor: 4.101

7.  Determinant role for the gep oncogenes, Gα12/13, in ovarian cancer cell proliferation and xenograft tumor growth.

Authors:  Ji Hee Ha; Rohini Gomathinayagam; Mingda Yan; Muralidharan Jayaraman; Rajagopal Ramesh; Danny N Dhanasekaran
Journal:  Genes Cancer       Date:  2015-07

Review 8.  Wnt3a: functions and implications in cancer.

Authors:  Sha He; Yi Lu; Xia Liu; Xin Huang; Evan T Keller; Chao-Nan Qian; Jian Zhang
Journal:  Chin J Cancer       Date:  2015-09-14

9.  Evidence of a common mechanism of disassembly of adherens junctions through Gα13 targeting of VE-cadherin.

Authors:  Haixia Gong; Xiaopei Gao; Shaoting Feng; M Rizwan Siddiqui; Alexander Garcia; Marcelo G Bonini; Yulia Komarova; Stephen M Vogel; Dolly Mehta; Asrar B Malik
Journal:  J Exp Med       Date:  2014-03-03       Impact factor: 14.307

Review 10.  G Protein-Coupled Receptors in Cancer.

Authors:  Rachel Bar-Shavit; Myriam Maoz; Arun Kancharla; Jeetendra Kumar Nag; Daniel Agranovich; Sorina Grisaru-Granovsky; Beatrice Uziely
Journal:  Int J Mol Sci       Date:  2016-08-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.